Skip to main navigation
Lineage Cell Therapeutics
  • Company
    • About Us
    • Leadership
    • Board of Directors
    • Careers
    • Contact
  • Pipeline
    • Overview
    • OpRegen® for Dry AMD
    • OPC1
    • VAC2
  • Technology
    • Lineage Platform
    • Manufacturing
  • Media
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
      • Committee Composition
    • Analyst Coverage
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxy Information
      • 2018 AgeX and Form 10 Information Statement
      • 2019 Form 8937
    • E-mail Alerts
    • Contact IR
  • Menu

SEC Filing Details

Investor Relations

  • Investors Overview
  • Press Releases
  • Events and Presentations
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
  • Analyst Coverage
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
  • Financials & Filings
    • SEC Filings
    • Annual Report and Proxy Information
    • 2018 AgeX Form 10 and Information Statement
    • 2019 Form 8937
  • E-mail Alerts
  • Contact IR

SEC Filing Details

Document Details

Form
10-K
Filing Date
Mar 9, 2023
Document Date
Dec 31, 2022
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Lineage Cell Therapeutics, Inc.
Issuer
LINEAGE CELL THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL CALCULATION FILE
EX-101.DEF - XBRL DEFINITION FILE
EX-101.LAB - XBRL LABEL FILE
EX-101.PRE - XBRL PRESENTATION FILE
XML - XBRL INSTANCE DOCUMENT
© Copyright - Lineage Cell Therapeutics, Inc.   |   Terms of Use & Privacy   |   contact@lineagecell.com
  • Facebook
  • Twitter
  • RSS Feed
  • Email Alerts
Scroll to top